Hann, Michael M.
Former Senior Research Director GSK,
United Kingdom
2025 Rank: 125948
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 490 out of 112089 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 125948 | 145681 |
| Total Cites | 321 | 334 |
| H-index | 10 | 10 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 24 | 24 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 85 | 85 |
| Number of Single+First+Last Authored Papers | 25 | 25 |
| Total Cites to Single+First+Last Authored Papers | 128 | 128 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 294 | 302 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.11 |
| Self-Citation Percentage |
3.89%
|
|
Hann, Michael M.
GlaxoSmithKline plc.,
United Kingdom
2024 Rank: 162109
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 642 out of 105998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 162109 | 167153 |
| Total Cites | 294 | 315 |
| H-index | 9 | 11 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 13 | 13 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 65 | 65 |
| Number of Single+First+Last Authored Papers | 24 | 24 |
| Total Cites to Single+First+Last Authored Papers | 108 | 108 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 275 | 287 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.10 |
| Self-Citation Percentage |
6.67%
|
|
Hann, Michael M.
GlaxoSmithKline plc.,
United Kingdom
2023 Rank: 95041
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 319 out of 99369 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 95041 | 111093 |
| Total Cites | 348 | 357 |
| H-index | 11 | 11 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 19 | 19 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 104 | 104 |
| Number of Single+First+Last Authored Papers | 24 | 24 |
| Total Cites to Single+First+Last Authored Papers | 141 | 141 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 319 | 325 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.10 |
| Self-Citation Percentage |
2.52%
|
|
Hann, Michael M.
GlaxoSmithKline plc.,
United Kingdom
2022 Rank: 114730
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 400 out of 94672 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 114730 | 125108 |
| Total Cites | 271 | 283 |
| H-index | 10 | 10 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 17 | 17 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 99 | 100 |
| Number of Single+First+Last Authored Papers | 23 | 23 |
| Total Cites to Single+First+Last Authored Papers | 139 | 140 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 242 | 251 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.13 |
| Self-Citation Percentage |
4.24%
|
|
Hann, Michael M.
GlaxoSmithKline plc.,
United Kingdom
2021 Rank: 123732
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 426 out of 88725 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 123732 | 142266 |
| Total Cites | 422 | 439 |
| H-index | 11 | 11 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 25 | 25 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 139 | 141 |
| Number of Single+First+Last Authored Papers | 22 | 22 |
| Total Cites to Single+First+Last Authored Papers | 201 | 203 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 373 | 384 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
3.87%
|
|
Hann, Michael M.
GlaxoSmithKline plc.,
United Kingdom
2020 Rank: 94974
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 332 out of 80622 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 94974 | 103729 |
| Total Cites | 340 | 357 |
| H-index | 10 | 11 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 21 | 21 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 148 | 150 |
| Number of Single+First+Last Authored Papers | 22 | 22 |
| Total Cites to Single+First+Last Authored Papers | 203 | 205 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 283 | 296 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.21 |
| Self-Citation Percentage |
4.76%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.